A field guide to pharmacy benefit carriers in Canada — IDs, rejection codes, refill rules, and every phone number that actually picks up.
Use this directory to identify the likely adjudicator, card fields, plan workflow, and next action when a claim rejects. The plan response and current provider manual still control the final billing decision, so every operational use should be checked against the live claim screen or source pill beside the rule.
A CPhA intervention code tells the adjudicator why a claim was submitted despite a warning, coordination issue, or utilization-management block. The code should match an actual documented event: prescriber consultation, patient travel, therapy change, intolerance, or other defensible reason.
| Code | Scenario | Referenced by |
|---|
Most coordination errors come from billing the right plans in the wrong order. The practical sequence is: identify the legally required first payer, submit the primary claim, then send only the remaining eligible balance to the next payer or support card.
Provincial and public-health programs do not all run through the same claim pathway. Some are adjudicated at the pharmacy counter, some require forms or ministry approval, and some distribute medication directly through public-health clinics rather than through the normal benefit-card workflow.
Clinical-service billing is not only a DIN/PIN lookup. The service has to fit the patient, the encounter type, the pharmacist authority being used, and the Ministry notice or guidebook that funds the service.
Ontario Ministry of Health Product Identification Numbers (PINs) for publicly funded pharmacist clinical services. Every PIN in this panel was verified against current Ministry Executive Officer Notices.
EO Notices referenced: Minor Ailments (Jan 3, 2024) · Oral Antivirals (Jan 17, 2025) · Ontario Naloxone Program (Jan 28, 2025) · MedsCheck / POP / Smoking Cessation (Professional Pharmacy Services Guidebook)
The calculator and printable letter help organize the facts that ODB vacation-supply rules usually require: travel dates, days on hand, pickup timing, and whether the request is a 100-day or up-to-200-day supply. The pharmacy still has to confirm claim eligibility at adjudication.
Dear Pharmacy Staff,
Please accept this letter to verify that I, , will be travelling outside of Ontario from the dates listed below, and I am requesting a Vacation Supply of my medication(s) to cover the duration of my trip.
Below are my medications required for the duration of my trip:
| 1 | 7 | ||||
| 2 | 8 | ||||
| 3 | 9 | ||||
| 4 | 10 | ||||
| 5 | 11 | ||||
| 6 | 12 |
If there are additional medications, use the reverse side of this form.
All of the following must be met to qualify for Vacation Supply:
Form content merged from two pharmacy-specific ODB vacation supply forms with branding removed. Eligibility criteria per the ODB Reference Manual. ODB
Original-design static conversion source: MedsCheck worksheet
Patient assistance programs can reduce the out-of-pocket balance after a public or private claim, but each program controls its own molecule list, enrolment route, and coordination order. The claim should be treated as a separate support transaction layered onto the main benefit workflow.
The eSampling table is organized by strip family because compatibility matters at the counter. A replacement meter claim should match the exact model, pseudo-DIN, manufacturer group, serial or certificate field, and billed acquisition cost.
Canadian pharmacies bill manufacturer-sponsored glucometer replacements through TELUS Assure using the eSampling pathway (Carrier 80). Each manufacturer has its own Group number and serial/certificate format. All claims are billed only at acquisition cost — no markup, no dispensing fee.
The meters below are grouped by the test strip they use, so when a patient arrives with a box of strips, every compatible meter is listed together. Pseudo-DINs and pricing are from the current TELUS Assure sampling program; strip compatibility has been verified against each manufacturer.
| Model | Pseudo-DIN | Price |
|---|---|---|
| OneTouch Verio System Kit | 00990930 (Ontario: 00990962) | $54.99 |
| OneTouch Verio IQ | 990944 | $54.99 |
| OneTouch Verio Flex System Kit | 11669907 | $40.00 |
| OneTouch Verio Reflect | 991037 | $40.00 |
| Model | Pseudo-DIN | Price |
|---|---|---|
| OneTouch Ultra Mini | 990941 | $49.99 |
| OneTouch Ultra 2 | 990942 | $54.99 |
| OneTouch Ultra Smart | 990943 | $74.99 |
| Model | Pseudo-DIN | Price |
|---|---|---|
| FreeStyle Lite | 990970 | $54.99 |
| FreeStyle Freedom Lite | 990971 | $54.99 |
| Model | Pseudo-DIN | Price |
|---|---|---|
| FreeStyle Precision Neo | 990974 | $54.99 |
| Model | Pseudo-DIN | Price |
|---|---|---|
| Precision Xtra | 990972 | $54.99 |
| Model | Pseudo-DIN | Price |
|---|---|---|
| Accu-Chek Guide Set | 9991041 | $50.00 |
| Model | Pseudo-DIN | Price |
|---|---|---|
| Accu-Chek Aviva | 66661002 | $50.00 |
| Accu-Chek Aviva Nano | 66661003 | $50.00 |
| Model | Pseudo-DIN | Price |
|---|---|---|
| Contour Next | 55555550 | $45.00 |
| Contour Next EZ | 55555554 | $45.00 |
| Contour Next One | 55555559 | $45.00 |
| Contour Next Gen | 55555564 | $45.00 |
| Item | Pseudo-DIN | Fee |
|---|---|---|
| Sample Glucometer Training Fee | 55555557 | $12.00 |
Bill this pseudo-DIN to claim a training fee for glucometer instruction on an Ascensia sample. Confirm with TELUS Assure whether the fee is claimable in your province.
| Model | Pseudo-DIN | Price |
|---|---|---|
| GE 200 | 56560001 | $30.00 |
Prescriber lookup is most useful before applying a prescriber-ID override, resolving a license mismatch, or documenting an out-of-province authority check. The goal is not just to find a number; it is to preserve enough evidence to explain why the claim was accepted or corrected.
This table flags ODB-listed oral solids where the unit price does not scale cleanly by strength. It is useful for spotting cost anomalies, but it does not decide whether a higher-strength tablet can be split, whether the drug is scoreable, or whether the change is clinically appropriate for a specific patient.
| Generic Name | Price Ratio |
|---|---|
| Prednisone | 33.6× |
| Valsartan | 22.2× |
| Irbesartan | 20× |
| Clonidine HCl | 17.9× |
| Brexpiprazole | 16× |
| Citalopram (Citalopram Hydrobromide) | 13.4× |
| Aripiprazole | 12.1× |
| Pramipexole Dihydrochloride Monohydrate | 10.7× |
| Clopidogrel Bisulfate | 9.1× |
| Paroxetine HCl | 9.1× |
| Quetiapine | 9× |
| Quinapril | 8× |
| Carvedilol | 8× |
| Amlodipine (Amlodipine Besylate) | 6.7× |
| Atorvastatin Calcium | 6× |
| Candesartan Cilexetil | 6× |
| Gemfibrozil | 5.2× |
| Rosuvastatin Calcium | 5.2× |
| Edoxaban | 4× |
| Losartan Potassium | 4× |
| Sitagliptin | 4× |
| Rivaroxaban | 4× |
| Sumatriptan Succinate | 3.6× |
| Vortioxetine Hydrobromide | 3.5× |
| Repaglinide | 3.4× |
| Vardenafil HCl | 3.2× |
| Simvastatin | 3.2× |
| Propranolol | 3.2× |
| Glimepiride | 3.1× |
| Canagliflozin | 2.9× |
| Pravastatin Sodium | 2.8× |
| Enalapril Maleate | 2.8× |
| Lisinopril | 2.8× |
| Tadalafil | 2.7× |
| Doxazosin Mesylate | 2.6× |
| Clonazepam | 2.3× |
| Perindopril Erbumine | 2.3× |
| Dapagliflozin | 2× |
| Rizatriptan | 2× |
| Solifenacin Succinate | 2× |
| Almotriptan | 2× |
| Tolterodine L-Tartrate | 2× |
| Finerenone | 2× |
| Eletriptan | 2× |
| Olmesartan Medoxomil | 2× |
| Apixaban | 2× |
| Eplerenone | 2× |
| Telmisartan | 2× |
| Lorazepam | 2× |
| Dexamethasone | 2× |
| Escitalopram | 1.9× |
| Hydralazine HCl | 1.9× |
| Minoxidil | 1.8× |
| Ciprofloxacin | 1.8× |
| Levetiracetam | 1.8× |
| Rosiglitazone | 1.8× |
| Chlorpromazine | 1.7× |
| Meloxicam | 1.7× |
| Flurazepam | 1.7× |
| Spironolactone | 1.7× |
| Alprazolam | 1.7× |
| Saxagliptin | 1.7× |
| Fosinopril Sodium | 1.7× |
| Morphine Sulfate | 1.7× |
| Temazepam | 1.7× |
| Trimipramine | 1.7× |
| Risperidone | 1.7× |
| Captopril | 1.6× |
| Oxycodone HCl | 1.6× |
| Methyldopa | 1.6× |
| Hydrochlorothiazide | 1.4× |
| Pioglitazone HCl | 1.4× |
| Bromazepam | 1.4× |
| Betahistine Dihydrochloride | 1.4× |
| Bisoprolol Fumarate | 1.4× |
| Amitriptyline | 1.4× |
| Nitrazepam | 1.3× |
| Lithium Carbonate | 1.3× |
| Timolol Maleate | 1.3× |
| Hydromorphone HCl | 1.3× |
| Indapamide | 1.3× |
| Atenolol | 1.2× |
| Misoprostol | 1.2× |
| Midodrine HCl | 1.2× |
| Allopurinol | 1.2× |
| Triazolam | 1.2× |
| Pindolol | 1.2× |
| Labetalol HCl | 1.1× |
| Trazodone Hydrochloride | 1.1× |
| Famotidine | 1.1× |
| Cinacalcet | 1.1× |
| Metoprolol Tartrate | 1.1× |
FRx Insurance separates three kinds of information: primary-source rules, carrier or representative workflows, and community field notes. Primary-source rules should be preferred whenever a claim, audit, patient communication, or professional judgment depends on the answer.
FRx Insurance is an independent reference compendium for Canadian pharmacy professionals. It documents publicly available claim adjudication rules, rejection codes, intervention codes, and benefit programs across Canadian third-party payers and public drug plans.
The content is compiled from provider manuals, executive officer notices, regulatory authority publications, and other primary sources. Each entry is accompanied by a citation linking back to the original document where possible.
The standalone guide library explains how the database should be used: how to classify claim rejections, how to think about payer order, how to document vacation supplies, and how to verify source material before a claim is submitted. The guides live outside the main workflow so the lookup tool remains the primary interface.
This site is not affiliated with, endorsed by, or sponsored by any insurance carrier, pharmacy benefit manager, adjudicator, regulatory authority, or government body referenced herein. All trade names and trademarks remain the property of their respective owners.
Email: info@frxinsurance.ca
Corrections, source suggestions, broken links, privacy questions, and cookie questions are welcome. Do not send personal health information, patient identifiers, prescription numbers, claim reference numbers, prescriber identifiers, or carrier case numbers.
Full contact page: /contact/
Privacy policy: FRx does not operate user accounts and does not ask visitors to submit personal health information. Correction emails are used only to review and respond to the correction. Full policy: /privacy/.
Cookie policy: the lookup tool may use local browser storage for interface preferences such as concise mode and cookie choice. Full policy: /cookies/.
Advertising consent: when advertising is enabled, Google advertising may use cookies or personal data for ads personalization, measurement, fraud prevention, frequency capping, and reporting. The banner lets visitors accept or reject non-essential advertising cookies without blocking the tool.
Reference only — not a substitute for primary sources. The content on this site is provided for informational and educational purposes. It is compiled from publicly available documents and may not reflect the most current version of carrier policies, regulatory rules, or drug benefit formularies. Always consult the relevant carrier's pharmacy provider manual, the Ontario Drug Programs Reference Manual, or other authoritative primary source before making claim adjudication or clinical decisions.
No warranty. This site is provided "as is" without any representations or warranties, express or implied. The operator makes no representations or warranties about the accuracy, completeness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or any losses, injuries, or damages arising from its display or use.
Not professional advice. Nothing on this site constitutes legal, financial, clinical, or professional advice. Pharmacists and other healthcare professionals are responsible for exercising their own professional judgment and for complying with the regulatory and legislative requirements of their jurisdiction.
Third-party trademarks. All carrier names, adjudicator names, drug brand names, product names, trademarks, and logos referenced on this site are the property of their respective owners. Their use on this site is solely for purposes of identification and reference and does not imply endorsement or affiliation.
Jurisdiction. Use of this site is governed by the laws of the Province of Ontario and the federal laws of Canada applicable therein.
Contact. Questions about these terms may be sent to info@frxinsurance.ca.